June 16th, 2016 by FGadmin
Fresh Gravity names Dan Sandiford as Managing Director for ANZ Region
Silicon Valley technology services firm appoints Dan Sandiford to spearhead its business in Australia and New Zealand
SANTA CLARA, CA – Fresh Gravity announced today that Dan Sandiford has joined the firm as Managing Director of ANZ region. He brings more than 20 years of experience in technology consulting, including leadership positions at Vodafone, ThoughtWorks, Infosys and Pactera. His prior experience includes leading sales, consulting and outsourced delivery teams. Most recently Dan was a Vice President at the Chinese originated Pactera Technologies International where he ran a consulting and technology business unit in the ANZ region.
“ANZ is a very strategic market for us and an important part of our global reach. Fresh Gravity will focus on key clients in the region to bring innovation to their digital journeys,” said Ajit Kumbhare, Founder & CEO of Fresh Gravity.
While welcoming Dan to Fresh Gravity, Nilesh Dhingra, Fresh Gravity’s Co-Founder and Co-CEO said “Dan’s illustrious background, his experience, leadership and vision will be a critical asset for Fresh Gravity in helping our clients achieve digital success.”
Dan is based in Sydney, Australia.
About Fresh Gravity
Founded in March 2015, Fresh Gravity is working to change the way enterprises use new and emerging technologies. With its Gravity Labs and global Head Quarters in Santa Clara, California, and offices in Sydney, Australia and Pune, India, the company boasts a staff of seasoned technologists who are experienced in a broad range of software and hardware solutions.
We are thrilled to share that on April 8th we celebrated the ninth anniversary of Fresh Gravity’s founding. It’s an incredible milestone that wouldn’t have been possible without the hard work, dedication, and unwavering commitment of the Fresh Gravity family. We would also like to thank all our clients and partners for trusting us. Thank […]
» READ MOREImagine this: you’re working on a new drug, a potential lifesaver. Every decision you make relies on the data you collect. If that data is shaky, well, that life-saving drug could turn dangerous fast. Scary, right? In the highly regulated sectors of pharmaceuticals, biotechnology, and medical devices, adherence to Good Practice (GxP) guidelines is paramount. […]
» READ MORE
Leave a Reply